Panaxium COO Jonathan Balfour presents novel brain machine interface device platform at OBIO Investment Summit 2023 in Toronto, Canada.
Dr. Gilles Huberfeld to Lead First In-Human Trial of Panaxium’s Next-Generation Brain Computer Interface
Dr. Gilles Huberfeld, MD, PhD, is leading the 1st humans patient investigations of Panaxium’s next-generation iontronic brain computer interface in 2023 in Paris, France.